AHB(SH:688639) Zheng Quan Ri Bao Zhi Sheng·2026-01-16 15:12Core Viewpoint - The company, Huaheng Biological, is currently operating normally and has no undisclosed matters at this time [1] Group 1: Company Operations - The company confirmed that its operations are normal and there are no undisclosed matters [1] - The company submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on September 30, 2025 [1] Group 2: Regulatory Approval - The issuance and listing of H-shares require approval from the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange [1] - There is uncertainty regarding the approval process for the H-share issuance and listing [1] Group 3: Information Disclosure - The company will fulfill its information disclosure obligations in accordance with the progress of the H-share issuance and listing [1] - Investors are advised to pay attention to investment risks related to this matter [1]